Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrotic Disease”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Not applicableEnrolling By InvitationNCT06885515
What this trial is testing

Telomeres Length in Israeli Fibrotic ILD Patients

Who this might be right for
Pulmonary Fibrosis
Barzilai Medical Center 100
Post-approval studies (Phase 4)UnknownNCT03260556
What this trial is testing

Pirfenidone for Progressive Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
University of Cincinnati 60
Not applicableStudy completedNCT02044939
What this trial is testing

Pulmonary Rehabilitation in Patients With Sarcoidosis

Who this might be right for
Stage 4 Pulmonary Sarcoidosis
University Hospital, Lille 38
Early research (Phase 1)Study completedNCT03530995
What this trial is testing

Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers

Who this might be right for
Drug-drug InteractionAutoimmune DiseasesFibrotic Disease
Kadmon Corporation, LLC 73
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Testing effectiveness (Phase 2)UnknownNCT01450644
What this trial is testing

Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease

Who this might be right for
Lung Disease
Royal Marsden NHS Foundation Trust 52
Testing effectiveness (Phase 2)Study completedNCT04480710
What this trial is testing

CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

Who this might be right for
NASH - Nonalcoholic SteatohepatitisFibrosis, LiverNAFLD - Nonalcoholic Fatty Liver Disease
Hepion Pharmaceuticals, Inc. 47
Not applicableStudy completedNCT04417920
What this trial is testing

Express Implant Versus Trabeculectomy After Late Failure Trabeculectomy

Who this might be right for
Glaucoma
Menoufia University 28
Post-approval studies (Phase 4)Study completedNCT05799755
What this trial is testing

Myositis Interstitial Lung Disease Nintedanib Trial

Who this might be right for
Myositis Associated Interstitial Lund Disease (MA-ILD)
Rohit Aggarwal, MD 49
Not applicableStudy completedNCT03852238
What this trial is testing

Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Bordeaux 283
Post-approval studies (Phase 4)Study completedNCT02286063
What this trial is testing

Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)

Who this might be right for
Lung; Disease, Fibroid (Chronic)
Royal Brompton & Harefield NHS Foundation Trust 70
Not applicableStudy completedNCT05130034
What this trial is testing

Home-based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Mayo Clinic 81
Testing effectiveness (Phase 2)Ended earlyNCT01898377
What this trial is testing

Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children

Who this might be right for
Chronic Graft-versus-host Disease
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05983471
What this trial is testing

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisCoughIPF+3 more
Melius Pharma AB 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06758739
What this trial is testing

Comparison of Curcumin and Intralesional Steroids in Oral Submucous Fibrosis

Who this might be right for
Oral Submucous Fibrosis
Services Institute of Medical Sciences, Pakistan 70
Not applicableStudy completedNCT01634919
What this trial is testing

Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and Ribavirin

Who this might be right for
Chronic Hepatitis C
Seoul National University Boramae Hospital 55
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Not applicableLooking for participantsNCT04942080
What this trial is testing

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

Who this might be right for
Myeloproliferative NeoplasmEssential ThrombocythemiaPrimary Myelofibrosis, Prefibrotic Stage+1 more
University Hospital, Angers 260
Testing effectiveness (Phase 2)Looking for participantsNCT06189820
What this trial is testing

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

Who this might be right for
Pulmonary FibrosisLung FibrosisIdiopathic Pulmonary Fibrosis+1 more
Erasme University Hospital 70
Not applicableStudy completedNCT04316780
What this trial is testing

Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes

Who this might be right for
Idiopathic Pulmonary Fibrosis
Steward St. Elizabeth's Medical Center of Boston, Inc. 320
Load More Results